ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

LeafyRX Expands Medical Marijuana Telehealth Services Nationwide

LeafyRX believes the expanded service will enable it to reach even more patients, providing a safe and legal channel to obtain medicinal cannabis from licensed doctors.

-- Medical cannabis card platform, LeafyRX, is pleased to announce it will be expanding its medical marijuana telehealth services nationwide. The new approach will allow patients from across the U.S. to get in touch with licensed medical doctors to obtain the permissions they need to use cannabis and related medicines.

“We’re very happy to be offering our clients this extended service,” explains company executive, Ellen Ernst. “It means that patients can explore their options wherever they are in the country and find physicians willing to help them obtain their MMJ quickly.”

LeafyRX’s service assists patients by enabling digital consultations with licensed doctors via the brand’s platform. The goal of these meetings is to determine whether a health condition they have warrants the use of medical marijuana, provided it is legal in their state.

The service is designed to be as speedy and as efficient as possible. LeafyRX knows patients seeking medicinal cannabis have often been through conventional treatments and therapies that have failed.

During the onboarding process, LeafyRX offers support and guidance. It tells patients how much medical marijuana they’re entitled to under the program, and appropriate dosages once they get the required sign-off from their doctor. Usually, the form of the cannabis (oils, flowers, or capsules) depends on the nature of the patient’s condition.

So far, over 100,000 patients have used LeafyRX’s services. With the national rollout of telehealth appointments, the platform hopes to grow that number further so more people can benefit from the potential positive effects of medical cannabis.

One patient said that using LeafyRX was “better than going to a clinic.” Another said that the service was “quick and efficient” and that the doctor he saw was respectful and didn’t try to rush anything.

“Our proven process means that more people are trusting LeafyRX to obtain legal access to medical marijuana than ever before,” Ernst says. “Every day, we have people signing up for customized treatment plans and the surety that patients themselves are meeting all legal requirements.”

For more information about LeafyRX, use the contact details below:

Contact Info:
Name: Ellen Ernst
Email: Send Email
Organization: LeafyRX
Address: 131 Continental Drive, Suite 301 Newark, New Castle 19713-4323, United States
Phone: +14153252681
Website: https://leafyrx.org/

Release ID: 89175986

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.87
-1.82 (-0.78%)
AAPL  267.46
-4.95 (-1.82%)
AMD  240.52
-6.29 (-2.55%)
BAC  51.48
-1.13 (-2.15%)
GOOG  285.60
+8.62 (3.11%)
META  602.01
-7.45 (-1.22%)
MSFT  507.49
-2.69 (-0.53%)
NVDA  186.60
-3.57 (-1.88%)
ORCL  219.86
-2.99 (-1.34%)
TSLA  408.92
+4.57 (1.13%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.